| 1. |
Describe how HIV is transmitted and dispel some of the common misconceptions about how one cannot get HIV. |
| 2. |
Describe the presence and possibility of transmission of HIV in households, foodŽservice establishments, through kissing, biting, saliva, tears, sweat and insects. |
| 3. |
Describe the natural history of HIV infection in adults and the progression of the disease to AIDS. |
| 4. |
Discuss the CDC system for classifying HIV infection and AIDS in adults and adolescents in the U.S. and identify clinical conditions under each of the three categories. |
| 5. |
Define "viral set-point" and indicate its use in predicting the rate of future progression of the illness. |
| 6. |
List various laboratory tests used as indicators of prognosis and/or stage of illness in HIV infection and weigh their advantages and disadvantages. |
| 7. |
List host factors, viral factors, acquired factors and clinical indicators that influence the rate of HIV -disease progression. |
| 8. |
Identify the three primary routes of HIV transmission and indicate the relative risk of infection. |
| 9. |
Discuss the three factors-infectiousness of the host, susceptibility of the recipient and the quantity and infectivity of the virus-that influence the transmission of HIV infection. |
| 10. |
Identify the HIV / AIDS prevention needs of women. |
| 11. |
Address the special challenges posed to the prevention of HIV epidemic in the African American community. |
| 12. |
Describe the epidemiology of HIV/AIDS among Hispanics in the U.S. and compare HIV exposure risks for U.S.-born Hispanics and Hispanics born in their countries. |
| 13. |
Describe the epidemiology of HIV/AIDS among America's youth. |
| 14. |
Describe the standard screening test for antibody to HIV and contrast it with the rapid HIV testing. |
| 15. |
Discuss the various advantages and disadvantages of rapid HIV test as compared to an EIA. |
| 16. |
Understand the importance of measuring HIV-RNA blood levels (viral load.) |
| 17. |
Explain what "undetectable" level of HIV in the blood means. |
| 18. |
List 5 steps for the correct use of condoms. |
| 19. |
Make the connection between sexually transmitted diseases and HIV and explain how other STDs facilitate HIV transmission. |
| 20. |
Point to the new evidence of the effectiveness of STD treatment in HIV prevention. |
| 21. |
Point to statistics showing the effectiveness of condoms in preventing HIV and STDs. |
| 22. |
Discuss the study sponsored by the CDC that quantified the risk of HIV infection associated with oral transmission. |
| 23. |
Describe the prevalence of HIV among men who have sex with men and outline the measures to combat the spread of STDs and HIV in this population group. |
| 24. |
Describe the risk of HI V transmission among women who have sex with women and list 3 specific measures that should be taken to reduce their risk of contracting HIV. |
| 25. |
Discuss the injection drug use and the transmission of HIV and other blood-borne infections. |
| 26. |
Make 3 specific recommendations to drug users who continue to inject to reduce the public and individual health risks. |
| 27. |
Describe the extent of the problem in curbing the transmission of HIV and other blood-borne diseases in the intravenous drug-using (IDU) population. |
| 28. |
Enunciate the 4 basic principles underlying the comprehensive approach to working with IDUs. |
| 29. |
Define universal precautions and list body fluids to which universal precautions apply and those to which they do not apply. |
| 30. |
Discuss precautions that a healthcare worker should take for other body fluids in special settings. |
| 31. |
Describe general guidelines for healthcare workers in the use of protective barriers. |
| 32. |
Discuss why the routine use of gloves for all phlebotomies is not necessary. |
| 33. |
Identify general guidelines in the selection and use of gloves in healthcare settings |
| 34. |
Evaluate the risk healthcare workers face of getting HIV on the job. |
| 35. |
Evaluate the risk of patients in a dentist's or doctor's office of getting HIV. |
| 36. |
Review the effectiveness of HIV prevention programs targeted toward changing personal behaviors, sexual education, intravenous drug users, HIV -infected pregnant women, blood banks and healthcare workers. |
| 37. |
Recount the dramatic success of protease inhibitors in the treatment of patients infected with HIV. |
| 38. |
Answer specific questions of people living with HIV/AIDS, including progression to AIDS, opportunistic infections, antiretroviral drug therapy and safe sexual behavior. |